NCT04658836View on ClinicalTrials.gov

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

October 31, 2021

Conditions
Vestibular Schwannoma
Interventions
DRUG

Triamcinolone Acetonide 40mg/mL

Intratympanic application of triamcinolone acetonide

Trial Locations (1)

1090

Medical University of Vienna (AKH), Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04658836 - Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF | Biotech Hunter | Biotech Hunter